A5049839308- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Gastric Cancer Management and Outcomes
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Esophageal Cancer Research and Treatment
- RNA modifications and cancer
- Lung Cancer Diagnosis and Treatment
- Immunotherapy and Immune Responses
- Neuroendocrine Tumor Research Advances
- Cancer-related molecular mechanisms research
- Cancer Cells and Metastasis
- Circular RNAs in diseases
Nanjing Medical University
2025
Shanxi Medical University
2024
Shanxi Provincial Cancer Hospital
2016-2023
Abstract Long noncoding RNA MIR17HG was involved with the progression of non‐small‐cell lung cancer (NSCLC), but specific mechanisms MIR17HG‐mediated immune escape NSCLC cells were still unknown. The present study investigated function on regulatory T cell (Treg)‐mediated and underlying in NSCLC. Expression miR‐17‐5p tissue samples detected using quantitative real‐time PCR (qRT‐PCR). A549 H1299 transfected sh‐MIR17HG, inhibitor, or sh‐MIR17HG + followed by cocultured Tregs. Cell...
Monitoring changes in serum tumor marker concentrations can help the early diagnosis of non-small cell lung cancer (NSCLC). However, there are few methods to monitor efficacy and prognosis radiotherapy NSCLC patients. The present research aimed explore correlation between squamous carcinoma antigen (SCCA) cytokeratin 19 soluble fragment (CYFRA21-1) levels Serum CYFRA21-1 SCCA were detected with an automatic chemiluminescence immunoassay analyzer. Patients followed up by telephone at regular...